Article

Innovation leadership with AMARIS features SmartPulse Technology and TransPRK

Bruce Allan, MD, UK and David Kang, MD, South Korea, are SCHWIND users for many years. Both greatly appreciate the outstanding performance features offered by the SCHWIND AMARIS excimer laser technology. The company‘s spirit of innovation, their willingness to advance the art and science of refractive surgery, and their responsiveness to feedback. In this video, Dr. Allan and Dr. Kang comment on the sophisticated SCHWIND AMARIS features SmartPulse Technology and TransPRK.

 

 

Bruce Allan, MD, UK and David Kang, MD, South Korea, are SCHWIND users for many years. Both greatly appreciate the outstanding performance features offered by the SCHWIND AMARIS excimer laser technology. The company‘s spirit of innovation,  their willingness to advance the art and science of refractive surgery, and their responsiveness to feedback. In this video, Dr. Allan and Dr. Kang comment on the sophisticated SCHWIND AMARIS features SmartPulse Technology and TransPRK.  

Back to Eye-to-Eye Innovation Series  

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.